75 related articles for article (PubMed ID: 28475008)
1. Experimental verification of a predicted intronic microRNA in human NGFR gene with a potential pro-apoptotic function.
Parsi S; Soltani BM; Hosseini E; Tousi SE; Mowla SJ
PLoS One; 2012; 7(4):e35561. PubMed ID: 22558167
[TBL] [Abstract][Full Text] [Related]
2. miR-155 as a Biomarker in B-Cell Malignancies.
Due H; Svendsen P; Bødker JS; Schmitz A; Bøgsted M; Johnsen HE; El-Galaly TC; Roug AS; Dybkær K
Biomed Res Int; 2016; 2016():9513037. PubMed ID: 27294145
[TBL] [Abstract][Full Text] [Related]
3. Identification of serum microRNAs as potential biomarkers in Pompe disease.
Carrasco-Rozas A; Fernández-Simón E; Lleixà MC; Belmonte I; Pedrosa-Hernandez I; Montiel-Morillo E; Nuñez-Peralta C; Llauger Rossello J; Segovia S; De Luna N; Suarez-Calvet X; Illa I; ; Díaz-Manera J; Gallardo E
Ann Clin Transl Neurol; 2019 Jul; 6(7):1214-1224. PubMed ID: 31353854
[TBL] [Abstract][Full Text] [Related]
4. CRISPR-Cas knockout of miR21 reduces glioma growth.
Nieland L; van Solinge TS; Cheah PS; Morsett LM; El Khoury J; Rissman JI; Kleinstiver BP; Broekman MLD; Breakefield XO; Abels ER
Mol Ther Oncolytics; 2022 Jun; 25():121-136. PubMed ID: 35572197
[TBL] [Abstract][Full Text] [Related]
5. mRNA and microRNA expression patterns in adrenocortical cancer.
Zsippai A; Szabó DR; Szabó PM; Tömböl Z; Bendes MR; Nagy Z; Rácz K; Igaz P
Am J Cancer Res; 2011; 1(5):618-28. PubMed ID: 21994902
[TBL] [Abstract][Full Text] [Related]
6. Identification of circular RNAs as a promising new class of diagnostic biomarkers for human breast cancer.
Lü L; Sun J; Shi P; Kong W; Xu K; He B; Zhang S; Wang J
Oncotarget; 2017 Jul; 8(27):44096-44107. PubMed ID: 28484086
[TBL] [Abstract][Full Text] [Related]
7. Characterization of mouse serum exosomal small RNA content: The origins and their roles in modulating inflammatory response.
Zhou X; Jiao Z; Ji J; Li S; Huang X; Lu X; Zhao H; Peng J; Chen X; Ji Q; Ji Y
Oncotarget; 2017 Jun; 8(26):42712-42727. PubMed ID: 28514744
[TBL] [Abstract][Full Text] [Related]
8. Altered expression of four miRNA (miR-1238-3p, miR-202-3p, miR-630 and miR-766-3p) and their potential targets in peripheral blood from vitiligo patients.
Shang Z; Li H
J Dermatol; 2017 Oct; 44(10):1138-1144. PubMed ID: 28500632
[TBL] [Abstract][Full Text] [Related]
9. Identification of aberrantly expressed long non-coding RNAs in stomach adenocarcinoma.
Gu J; Li Y; Fan L; Zhao Q; Tan B; Hua K; Wu G
Oncotarget; 2017 Jul; 8(30):49201-49216. PubMed ID: 28484081
[TBL] [Abstract][Full Text] [Related]
10. Circulating liver cancer stem cells and their stemness-associated MicroRNAs as diagnostic and prognostic biomarkers for viral hepatitis-induced liver cirrhosis and hepatocellular carcinoma.
Hassan M; Nasr SM; Amin NA; El-Ahwany E; Zoheiry M; Elzallat M
Noncoding RNA Res; 2023 Jun; 8(2):155-163. PubMed ID: 36632614
[TBL] [Abstract][Full Text] [Related]
11. Orthologs of human circulating miRNAs associated with hepatocellular carcinoma are elevated in mouse plasma months before tumour detection.
Ding LH; Fallgren CM; Yu Y; McCarthy M; Edmondson EF; Ullrich RL; Weil MM; Story MD
Sci Rep; 2022 Jun; 12(1):10927. PubMed ID: 35764780
[TBL] [Abstract][Full Text] [Related]
12. Microfluidics for detection of exosomes and microRNAs in cancer: State of the art.
Mousavi SM; Amin Mahdian SM; Ebrahimi MS; Taghizadieh M; Vosough M; Sadri Nahand J; Hosseindoost S; Vousooghi N; Javar HA; Larijani B; Hadjighassem MR; Rahimian N; Hamblin MR; Mirzaei H
Mol Ther Nucleic Acids; 2022 Jun; 28():758-791. PubMed ID: 35664698
[TBL] [Abstract][Full Text] [Related]
13. CircRFX3 contributes to glioma progression through the circRFX3-miR-1179/miR-1229-VASP axis.
Li H; Zhang Y; Song H; Li L
Cancer Cell Int; 2021 Nov; 21(1):588. PubMed ID: 34727925
[TBL] [Abstract][Full Text] [Related]
14. M2 macrophage-derived exosomal microRNAs inhibit cell migration and invasion in gliomas through PI3K/AKT/mTOR signaling pathway.
Yao J; Wang Z; Cheng Y; Ma C; Zhong Y; Xiao Y; Gao X; Li Z
J Transl Med; 2021 Mar; 19(1):99. PubMed ID: 33676540
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of miR-1825 inhibits the progression of glioblastoma by suppressing CDK14 though Wnt/β-catenin signaling pathway.
Lu F; Li C; Sun Y; Jia T; Li N; Li H
World J Surg Oncol; 2020 Jun; 18(1):147. PubMed ID: 32605563
[TBL] [Abstract][Full Text] [Related]
16. Circulating microRNAs as potential cancer biomarkers: the advantage and disadvantage.
Wang H; Peng R; Wang J; Qin Z; Xue L
Clin Epigenetics; 2018; 10():59. PubMed ID: 29713393
[TBL] [Abstract][Full Text] [Related]
17. MiR-634 sensitizes glioma cells to temozolomide by targeting CYR61 through Raf-ERK signaling pathway.
Tan Z; Zhao J; Jiang Y
Cancer Med; 2018 Mar; 7(3):913-921. PubMed ID: 29473317
[TBL] [Abstract][Full Text] [Related]
18. Sources to variability in circulating human miRNA signatures.
Keller A; Rounge T; Backes C; Ludwig N; Gislefoss R; Leidinger P; Langseth H; Meese E
RNA Biol; 2017 Dec; 14(12):1791-1798. PubMed ID: 28820329
[TBL] [Abstract][Full Text] [Related]
19. A novel serum microRNA-based identification and classification biomarker of human glioma.
Xing W; Zeng C
Tumour Biol; 2017 May; 39(5):1010428317705339. PubMed ID: 28475008
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
